An Evaluation of US Food and Drug Administration’s Program to Register HIV Drugs for Use in Resource-Constrained Settings

IMPORTANCE: The US Food and Drug Administration (FDA) program to review antiretroviral drugs for use in low-resource settings via the US President’s Emergency Plan for AIDS Relief (PEPFAR) now supports treatment of more than 14 million patients with HIV. However, an in-depth evaluation of the progra...

Descripción completa

Detalles Bibliográficos
Autores principales: Chahal, Harinder Singh, Koukounas, Kalli, Capella, Peter, Presto, Ryan, Murray, Jeffrey S., Shimer, Martin, Riley, Karen, Valdez, Mary Lou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902815/
https://www.ncbi.nlm.nih.gov/pubmed/31747034
http://dx.doi.org/10.1001/jamanetworkopen.2019.15787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902815/
https://www.ncbi.nlm.nih.gov/pubmed/31747034
http://dx.doi.org/10.1001/jamanetworkopen.2019.15787

Ejemplares similares